116 related articles for article (PubMed ID: 14748875)
1. Surveillance for newly acquired hepatitis C in Australia.
Robotin MC; Copland J; Tallis G; Coleman D; Giele C; Carter L; Spencer J; Kaldor JM; Dore GJ
J Gastroenterol Hepatol; 2004 Mar; 19(3):283-8. PubMed ID: 14748875
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hepatitis C virus infection in Australia.
Dore GJ; Law M; MacDonald M; Kaldor JM
J Clin Virol; 2003 Feb; 26(2):171-84. PubMed ID: 12600649
[TBL] [Abstract][Full Text] [Related]
3. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.
Wu HX; Wu J; Wong T; Donaldson T; Dinner K; Andonov A; Ip Chan J; Moffat B; Baptiste B; Furseth J; Poliquin D; Bolesnikov G; Giulivi A; Paton S
Scand J Infect Dis; 2006; 38(6-7):482-9. PubMed ID: 16798699
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C enhanced surveillance: results from a southeastern Sydney pilot program.
Bateman-Steel CR; Smedley EJ; Kong M; Ferson MJ
Public Health Res Pract; 2015 Mar; 25(2):e2521520. PubMed ID: 25848738
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
Gidding HF; Topp L; Middleton M; Robinson K; Hellard M; McCaughan G; Maher L; Kaldor JM; Dore GJ; Law MG
J Gastroenterol Hepatol; 2009 Oct; 24(10):1648-54. PubMed ID: 19798783
[TBL] [Abstract][Full Text] [Related]
6. Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications.
Guy R; Devadason D; Lim M; Higgins N; Pedrana A; Gibson K; Lewis J; Spelman T; White B; Kaldor J; Hellard M
Commun Dis Intell Q Rep; 2008 Jun; 32(2):250-6. PubMed ID: 18767425
[TBL] [Abstract][Full Text] [Related]
7. Improving surveillance for acute hepatitis C.
Deacon RM; Wand H; Stelzer-Braid S; Treloar C; Maher L
Commun Dis Intell Q Rep; 2011 Mar; 35(1):16-20. PubMed ID: 21698979
[TBL] [Abstract][Full Text] [Related]
8. Childhood hepatitis C virus infection: An Australian national surveillance study of incident cases over five years.
Raynes-Greenow C; Polis S; Elliott E; Hardikar W; Kesson A; Kaldor J; Jones CA
J Paediatr Child Health; 2015 Nov; 51(11):1115-20. PubMed ID: 25940977
[TBL] [Abstract][Full Text] [Related]
9. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
10. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
[TBL] [Abstract][Full Text] [Related]
11. Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men.
Medland NA; Chow EP; Bradshaw CS; Read TH; Sasadeusz JJ; Fairley CK
BMC Infect Dis; 2017 Mar; 17(1):185. PubMed ID: 28253838
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C prevalence--a nationwide serosurvey.
Amin J; Gidding H; Gilbert G; Backhouse J; Kaldor J; Dore G; Burgess M
Commun Dis Intell Q Rep; 2004; 28(4):517-21. PubMed ID: 15745402
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hepatitis C virus infection among injecting drug users in Australia.
Crofts N; Jolley D; Kaldor J; van Beek I; Wodak A
J Epidemiol Community Health; 1997 Dec; 51(6):692-7. PubMed ID: 9519134
[TBL] [Abstract][Full Text] [Related]
15. Modelling the hepatitis C virus epidemic in Australia.
Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
[TBL] [Abstract][Full Text] [Related]
16. Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group.
Law MG
J Gastroenterol Hepatol; 1999 Nov; 14(11):1100-7. PubMed ID: 10574138
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis B in Poland in 2010].
Stepień M; Czarkowski MP
Przegl Epidemiol; 2012; 66(2):277-85. PubMed ID: 23101217
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
Falster K; Kaldor JM; Maher L;
J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
[TBL] [Abstract][Full Text] [Related]
19. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.
May S; Ngui SL; Collins S; Lattimore S; Ramsay M; Tedder RS; Ijaz S
J Clin Virol; 2015 Mar; 64():6-11. PubMed ID: 25728071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
